Last 48 quarters of trend data · Healthcare · Diagnostics & Lab Testing
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -45.71 | — | — | — | — | 8.46 | — | — | — | — | — | — | — | 837.68 | 170.14 | 117.00 | — | 104.50 | 47.25 | 177.44 | 100.33 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | +701.6% | +260.1% | -34.1% | — | +52.8% | -38.6% | +107.9% | +62.2% | |
| P/S Ratio | 2.90 | 2.83 | 2.17 | 2.89 | 1.45 | 1.49 | 1.41 | 2.47 | 3.32 | 4.31 | 3.01 | 4.07 | 4.00 | 5.47 | 3.91 | 4.38 | 3.96 | 4.26 | 5.09 | 7.53 | 8.31 |
| — | +89.7% | +53.6% | +17.3% | -56.5% | -65.4% | -53.1% | -39.3% | -16.9% | -21.3% | -23.2% | -7.2% | +0.9% | +28.5% | -23.2% | -41.7% | -52.3% | -53.8% | -47.9% | -20.1% | -3.3% | |
| P/B Ratio | 1.22 | 1.21 | 0.93 | 1.16 | 0.62 | 0.59 | 0.61 | 0.82 | 1.15 | 1.19 | 0.91 | 1.18 | 1.17 | 1.59 | 1.21 | 1.22 | 1.17 | 2.55 | 3.22 | 4.41 | 5.01 |
| — | +105.1% | +51.9% | +41.8% | -46.4% | -50.6% | -32.2% | -30.7% | -1.3% | -25.2% | -25.0% | -3.4% | -0.6% | -37.5% | -62.4% | -72.2% | -76.6% | -53.9% | -45.8% | -19.0% | -1.4% | |
| P/FCF | 51.45 | 134.11 | — | 55.19 | 7.48 | — | 783.16 | — | 33.28 | — | 296.84 | — | — | — | 14.46 | — | — | — | 90.87 | — | 78.00 |
| — | — | — | — | -77.5% | — | +163.8% | — | — | — | +1953.2% | — | — | — | -84.1% | — | — | — | +6.8% | — | +22.7% | |
| EV / EBITDA | 29.07 | 28.60 | 19.70 | 30.04 | 20.68 | 36.67 | 22.15 | 17.81 | 20.30 | 29.31 | 17.59 | 26.92 | 24.79 | 29.89 | 21.79 | 26.91 | 58.57 | 45.52 | 29.42 | 75.15 | 58.58 |
| — | -22.0% | -11.1% | +68.7% | +1.8% | +25.1% | +26.0% | -33.8% | -18.1% | -1.9% | -19.3% | +0.0% | -57.7% | -34.3% | -25.9% | -64.2% | -0.0% | +7.1% | -37.4% | +48.4% | +46.8% | |
| EV / EBIT | — | — | 355.63 | — | — | 7.89 | — | 91.97 | — | 375.02 | 69.96 | 85.26 | 76.24 | 71.12 | 44.13 | 76.41 | — | 80.61 | 37.16 | 143.67 | 82.92 |
| — | — | — | — | — | -97.9% | — | +7.9% | — | +427.3% | +58.5% | +11.6% | — | -11.8% | +18.8% | -46.8% | — | +50.3% | -39.0% | +112.2% | +67.0% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 46.9% | 47.4% | 47.8% | 46.9% | 47.5% | 45.4% | 41.2% | 39.4% | 38.8% | 39.8% | 47.9% | 50.5% | 50.9% | 51.0% | 50.9% | 49.5% | 48.9% | 47.0% | 46.4% | 44.8% | 46.4% |
| — | +4.3% | +16.2% | +19.1% | +22.4% | +14.0% | -14.1% | -22.1% | -23.7% | -21.9% | -5.9% | +2.1% | +3.9% | +8.4% | +9.8% | +10.5% | +5.4% | +0.6% | +2.5% | -3.0% | +0.3% | |
| Operating Margin | -2.5% | -0.8% | 1.4% | -1.6% | -2.4% | -7.7% | -5.9% | 5.4% | 7.4% | 4.0% | 7.4% | 5.1% | 6.3% | 8.4% | 9.7% | 7.2% | -3.3% | 4.6% | 12.9% | 5.0% | 9.6% |
| — | +89.5% | +123.4% | -128.8% | -132.4% | -292.7% | -179.2% | +6.1% | +17.2% | -52.2% | -23.4% | -28.9% | +289.3% | +82.4% | -24.7% | +44.5% | -134.8% | -73.0% | -19.0% | -63.2% | -42.9% | |
| Net Margin | -0.9% | -5.3% | -5.0% | -8.0% | -7.1% | 17.4% | -271.5% | -5.0% | -197.3% | -5.8% | -2.3% | -0.9% | -1.5% | 0.7% | 2.3% | 3.8% | -18.2% | 3.9% | 10.7% | 4.2% | 8.3% |
| — | -130.7% | +98.2% | -62.3% | +96.4% | +398.9% | -11773.9% | -461.1% | -12893.4% | -985.4% | -199.2% | -123.5% | +91.7% | -83.3% | -78.4% | -11.6% | -319.2% | -70.4% | -13.7% | -63.0% | -39.9% |
| Metric | TTM | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -0.4% | -0.6% | -0.5% | -0.8% | -0.8% | 1.7% | -25.9% | -0.4% | -15.7% | -0.4% | -0.2% | -0.1% | -0.1% | 0.0% | 0.2% | 0.3% | -2.1% | 0.6% | 1.7% | 0.6% | 1.3% |
| — | -132.8% | +97.9% | -96.5% | +95.2% | +531.9% | -14927.2% | -539.5% | -14089.8% | -938.4% | -196.7% | -124.5% | +94.7% | -91.9% | -89.5% | -58.0% | -266.7% | -70.8% | -11.3% | -63.0% | -39.4% | |
| ROA | -0.2% | -0.4% | -0.3% | -0.5% | -0.5% | 1.1% | -16.4% | -0.3% | -10.7% | -0.3% | -0.1% | -0.0% | -0.1% | 0.0% | 0.1% | 0.2% | -1.5% | 0.5% | 1.5% | 0.6% | 1.1% |
| — | -133.6% | +97.9% | -86.8% | +95.6% | +483.9% | -13759.9% | -515.7% | -13913.4% | -940.9% | -196.0% | -124.4% | +95.0% | -93.8% | -91.9% | -67.7% | -232.4% | -71.3% | -13.4% | -63.9% | -40.2% | |
| ROIC | -0.6% | -0.1% | 0.1% | -0.1% | -0.1% | -0.4% | -0.3% | 0.3% | 0.3% | 0.2% | 0.3% | 0.2% | 0.3% | 0.4% | 0.4% | 0.3% | -0.2% | 0.6% | 1.6% | 0.6% | 1.2% |
| — | +88.3% | +127.0% | -134.3% | -141.8% | -357.0% | -193.1% | +15.3% | +23.8% | -55.1% | -24.4% | -23.8% | +215.7% | -33.7% | -72.1% | -48.6% | -120.9% | -73.3% | -20.3% | -65.6% | -45.0% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.38 | 0.37 | 0.38 | 0.38 | 0.38 | 0.37 | 0.44 | 0.34 | 0.33 | 0.28 | 0.29 | 0.28 | 0.28 | 0.28 | 0.29 | 0.28 | 0.30 | — | 0.00 | — | — |
| — | -0.8% | -14.0% | +12.4% | +12.7% | +31.5% | +52.9% | +18.7% | +18.3% | +0.7% | +0.7% | -0.0% | -5.0% | — | +17522.4% | — | — | — | +6.1% | — | — | |
| Debt / EBITDA | 8.38 | 28.36 | 24.41 | 30.97 | 33.67 | 61.13 | 39.34 | 21.59 | 18.94 | 23.19 | 17.79 | 21.53 | 20.25 | 18.57 | 17.31 | 20.50 | 48.42 | — | 0.06 | — | — |
| — | -53.6% | -38.0% | +43.4% | +77.8% | +163.7% | +121.2% | +0.3% | -6.4% | +24.9% | +2.8% | +5.0% | -58.2% | — | +28572.2% | — | — | — | +22.7% | — | — | |
| Current Ratio | 3.82 | 3.90 | 3.82 | 3.92 | 3.91 | 3.58 | 3.32 | 3.91 | 3.77 | 4.41 | 3.82 | 3.82 | 3.54 | 4.23 | 4.03 | 5.18 | 4.22 | 9.07 | 8.05 | 9.26 | 9.73 |
| — | +8.7% | +15.3% | +0.3% | +3.6% | -18.7% | -13.2% | +2.4% | +6.7% | +4.3% | -5.2% | -26.4% | -16.2% | -53.4% | -50.0% | -44.0% | -56.7% | -24.4% | -27.0% | -23.4% | -25.0% | |
| Quick Ratio | 2.91 | 2.92 | 2.91 | 2.84 | 2.80 | 2.26 | 2.22 | 2.45 | 2.46 | 2.79 | 2.59 | 2.66 | 2.63 | 3.21 | 3.11 | 3.84 | 3.33 | 7.15 | 6.48 | 7.53 | 8.02 |
| — | +29.1% | +31.1% | +16.0% | +13.8% | -18.9% | -14.4% | -7.9% | -6.3% | -13.1% | -16.6% | -30.7% | -21.0% | -55.1% | -52.0% | -49.0% | -58.6% | -28.4% | -29.2% | -24.1% | -26.4% | |
| Interest Coverage | 0.84 | -0.08 | 0.13 | -0.46 | -0.37 | 3.66 | -35.85 | 0.45 | -25.27 | 0.16 | 0.69 | 0.71 | 0.79 | 1.09 | 1.43 | 0.87 | -0.66 | 3329.50 | — | 189.80 | 587.64 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying NEOG stock.
Neogen Corporation's current P/E is -45.7x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Neogen Corporation's current operating margin is -2.5%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Neogen Corporation's business trajectory between earnings reports.